NCT06897228View on ClinicalTrials.gov

PANK-003 Cell Injection Combined with Standard Adjuvant Chemotherapy After Surgery in Patients with Solid Tumors

PHASE1RecruitingINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

February 18, 2024

Primary Completion Date

January 31, 2027

Study Completion Date

March 31, 2027

Conditions

Solid Tumors, Adult

Interventions

DRUG

PANK-003 cell injection

PANK-003 cell injection

Trial Locations (1)

455000

RECRUITING

AnYang Tumor Hospital, Anyang

All Listed Sponsors

lead

Shenzhen Celconta Life Science Co., Ltd.

INDUSTRY